Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Product Surveillance, Postmarketing »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Product Recalls and Withdrawals < Product Surveillance, Postmarketing < Progesterone  Facettes :

List of bibliographic references indexed by Product Surveillance, Postmarketing

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
001213 (2018) Tatsuya Atsumi [Japon] ; Keishi Fujio [Japon] ; Kunihiro Yamaoka [Japon] ; Minako Tomobe [Japon] ; Kazuyuki Kuroyanagi [Japon] ; Hideto Kameda [Japon]Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting.
001247 (2018) Tatsuya Atsumi [Japon] ; Yoshiaki Ando [Japon] ; Shinichi Matsuda [Japon] ; Shiho Tomizawa [Japon] ; Riwa Tanaka [Japon] ; Nobuhiro Takagi [Japon] ; Ayako Nakasone [Japon]Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database.
001983 (2016) Maria Hoeltzenbein [Allemagne] ; Evelin Beck [Allemagne] ; Richa Rajwanshi [États-Unis] ; Carina G Testam Skorpen [Norvège] ; Erhan Berber [États-Unis] ; Christof Schaefer [Allemagne] ; Monika Stensen [Norvège]Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data.
001987 (2016) Shumpei Yokota [Japon] ; Yasuhiko Itoh [Japon] ; Tomohiro Morio [Japon] ; Hideki Origasa [Japon] ; Naokata Sumitomo [Japon] ; Minako Tomobe [Japon] ; Kunihiko Tanaka [Japon] ; Seiji Minota [Japon]Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan.
001E60 (2015) Jeffrey R. Curtis [États-Unis] ; Susana Perez-Gutthann [Espagne] ; Samy Suissa [Canada] ; Pavel Napalkov [États-Unis] ; Natasha Singh [États-Unis] ; Liz Thompson [Royaume-Uni] ; Benjamin Porter-Brown [Royaume-Uni]Tocilizumab in rheumatoid arthritis: a case study of safety evaluations of a large postmarketing data set from multiple data sources.
001F14 (2015) Gerd Horneff [Oman]Safety of biologic therapies for the treatment of juvenile idiopathic arthritis.
002637 (2014) Takao Koike [Japon] ; Masayoshi Harigai [Japon] ; Shigeko Inokuma [Japon] ; Naoki Ishiguro [Japon] ; Junnosuke Ryu [Japon] ; Tsutomu Takeuchi [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Yoko Sano [Japon] ; Hitomi Yaguramaki [Japon] ; Hisashi Yamanaka [Japon]Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
003995 (2011) Takao Koike [Japon] ; Masayoshi Harigai [Japon] ; Shigeko Inokuma [Japon] ; Naoki Ishiguro [Japon] ; Junnosuke Ryu [Japon] ; Tsutomu Takeuchi [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Kyoko Ito [Japon] ; Hisashi Yamanaka [Japon]Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
003C69 (2010) Yasuharu Nakashima [Japon] ; Masakazu Kondo ; Hiroshi Harada ; Takahiko Horiuchi ; Takashi Ishinishi ; Hiroshi Jojima ; Koji Kuroda ; Hisaaki Miyahara ; Ryuji Nagamine ; Hitoshi Nakashima ; Takeshi Otsuka ; Isao Saikawa ; Eisuke Shono ; Eiichi Suematsu ; Tomomi Tsuru ; Ken Wada ; Yukihide IwamotoClinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Product Surveillance, Postmarketing" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Product Surveillance, Postmarketing" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Product Surveillance, Postmarketing
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021